11 research outputs found

    Male mice emit distinct ultrasonic vocalizations when the female leaves the social interaction arena.

    Get PDF
    Adult male mice emit large number of complex ultrasonic vocalizations (USVs) when interacting with adult females. Call numbers and call categories differ greatly among inbred mouse strains. Little is known about USV emissions when the social partner departs. To investigate whether call repertoires and call rates are different when the male is interacting with a female and after the removal of the female, we designed a novel male-female social interaction test in which vocalizations were recorded across three phases. During phase 1, the male subject freely interacts with an unfamiliar estrus female mouse in a clean cage for 5 min. During phase 2, the female is removed while the male remains in the cage for 3 min. During phase 3, the same female is returned to the cage to rejoin the male subject mouse for 3 min. C57BL/6J (B6), FVB.129P2-Pde6b(+) Tyr(c-ch)/Ant (FVB), and BTBR T+ tf/J (BTBR) male subject mice were tested in this paradigm. All three strains emitted USVs during their initial interaction with the female partner. When the female was reintroduced in phase 3, numbers of USVs were similar to the initial introductory phase 1. Strain comparisons indicated fewer calls in pairs of BTBR males and stimulus females than in pairs of B6 males and stimulus females and pairs of FVB males and stimulus females. In the absence of the female, all FVB males vocalized, while only one third of B6 males and one third of BTBR males vocalized. In all three strains, changes in call category repertoires were detected after the female was removed. Call categories reverted to the phase 1 pattern when the female was returned in phase 3. Present findings indicate that males of commonly used inbred strains emit USVs when a partner female leaves the testing arena, suggesting that removing a salient social stimulus may be a unique approach to elicit USVs from mice. Our three-phase paradigm may also be useful for studying attention to social cues, and qualitative differences in vocalizations when a social partner is present vs. suddenly absent

    Delayed Effect of Craniotomy on Experimental Seizures in Rats

    Get PDF
    <div><p>Neurosurgical therapeutic interventions include components that are presumed to be therapeutically inert, such as craniotomy and electrode implantation. Because these procedures may themselves exert neuroactive actions, with anecdotal evidence suggesting that craniotomy and electrode placement may have a particularly significant impact on epileptic seizures, the importance of their inclusion in sham control groups has become more compelling. Here we set out to test the hypothesis that craniotomy alone is sufficient to alter experimental seizures in rats. We tested adult male rats for seizures evoked by pentylenetetrazole (70 mg/kg) between 3 and 20 days following placement of bilateral craniotomies (either 2.5 or 3.5 mm in diameter) in the parietal bone of the skull, without penetrating the dura. Control (sham-operated) animals underwent anesthesia and surgery without craniotomy. We found that craniotomy significantly decreased the severity of experimental seizures on postoperative days 3, 6, and 10; this effect was dependent on the size of craniotomy. Animals with craniotomies returned to control seizure severity by 20 days post-craniotomy. These data support the hypothesis that damage to the skull is sufficient to cause a significant alteration in seizure susceptibility over an extended postoperative period, and indicate that this damage should not be considered neurologically inert.</p></div

    2.5/kg PTZ at 3 days post-operatively.

    No full text
    <p>Data are expressed as % of respective shams for animals with 2.5 mm craniotomies challenged with 50 or 70 mg/kg of PTZ. We normalized each treated group to the median of the matched sham control group (a value of 100% equals sham control response). The data shown for 70 mg/kg represent a transformation of the data shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0081401#pone-0081401-g002" target="_blank">Figure 2</a> for comparison purposes. Sham animals challenged with 50 mg/kg PTZ displayed a mean seizure score of 4.6 (median  = 3.5); those challenged with 70 mg/kg displayed a mean of 5.0 (median  = 3.5). Animals with craniotomies displayed means of 1.9 (median  = 2.25) and 3.7 (median  = 2.5) for 50 and 70 mg/kg challenge doses, respectively. * indicates significantly different than 100% (Wilcoxon Sign Rank test, P<0.05).</p

    Position and size of craniotomies in the parietal bone of the rat skull.

    No full text
    <p>SS =  sagittal suture, CS =  coronal suture, LS =  lambdoidal suture. Scale bar indicates 5 mm. 2.5 and 3.5 indicate the diameter of the craniotomy.</p

    Effect of craniotomy on seizure score and latency to seizure onset.

    No full text
    <p>(A) Seizure score as a function of group (i.e., Sham controls, 2.5 mm and 3.5 mm craniotomies) and post-operative testing day (3, 6, 10, and 20 days post-surgery). The numbers on each bar indicate the number of animals in each group. *  =  seizure score was significantly reduced as compared to the equivalent control (sham) group (P<0.05, Dunn's post-hoc). (B) Latency to seizure onset (in seconds) as a function of group (as described above). *  =  latency is significantly greater than sham controls (P<0.05, Dunnett's multiple comparison test).</p

    2.5/kg PTZ at 10 days post-operatively.

    No full text
    <p>Data are expressed as % of respective shams for animals with 2.5 mm craniotomies challenged with 70 or 90 mg/kg of PTZ. We normalized each treated group to the median of the matched sham control group (a value of 100% equals sham control response). The data shown for 70 mg/kg represent a transformation of the data shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0081401#pone-0081401-g002" target="_blank">Fig 2</a> for comparison purposes. Sham animals challenged with 90 mg/kg PTZ displayed a mean seizure score of 10.5 (median  = 10.5). Animals with craniotomies displayed means of 3.3 (median  = 3.5) and 11.57 (median  = 12) for 70 and 90 mg/kg challenge doses, respectively. * indicates significantly different than 100% (Wilcoxon Sign Rank test, P<0.05).</p

    Behavioral Abnormalities and Circuit Defects in the Basal Ganglia of a Mouse Model of 16p11.2 Deletion Syndrome

    Get PDF
    A deletion on human chromosome 16p11.2 is associated with autism spectrum disorders. We deleted the syntenic region on mouse chromosome 7F3. MRI and high-throughput single-cell transcriptomics revealed anatomical and cellular abnormalities, particularly in cortex and striatum of juvenile mutant mice (16p11+/−). We found elevated numbers of striatal medium spiny neurons (MSNs) expressing the dopamine D2 receptor (Drd2+) and fewer dopamine-sensitive (Drd1+) neurons in deep layers of cortex. Electrophysiological recordings of Drd2+ MSN revealed synaptic defects, suggesting abnormal basal ganglia circuitry function in 16p11+/− mice. This is further supported by behavioral experiments showing hyperactivity, circling, and deficits in movement control. Strikingly, 16p11+/− mice showed a complete lack of habituation reminiscent of what is observed in some autistic individuals. Our findings unveil a fundamental role of genes affected by the 16p11.2 deletion in establishing the basal ganglia circuitry and provide insights in the pathophysiology of autism
    corecore